1. Home
  2. REYN vs TGTX Comparison

REYN vs TGTX Comparison

Compare REYN & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reynolds Consumer Products Inc.

REYN

Reynolds Consumer Products Inc.

HOLD

Current Price

$24.46

Market Cap

4.9B

Sector

Industrials

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$29.55

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REYN
TGTX
Founded
1947
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.9B
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
REYN
TGTX
Price
$24.46
$29.55
Analyst Decision
Hold
Strong Buy
Analyst Count
7
6
Target Price
$25.43
$50.67
AVG Volume (30 Days)
1.2M
1.5M
Earning Date
05-06-2026
05-29-2026
Dividend Yield
3.71%
N/A
EPS Growth
N/A
1746.67
EPS
1.43
2.77
Revenue
$3,756,000,000.00
$2,785,000.00
Revenue This Year
$2.04
$90.97
Revenue Next Year
$1.82
$45.74
P/E Ratio
$17.30
$10.81
Revenue Growth
N/A
N/A
52 Week Low
$20.91
$25.37
52 Week High
$26.25
$46.48

Technical Indicators

Market Signals
Indicator
REYN
TGTX
Relative Strength Index (RSI) 56.10 48.55
Support Level $23.49 $27.25
Resistance Level $24.85 $30.00
Average True Range (ATR) 0.48 1.11
MACD 0.12 0.13
Stochastic Oscillator 74.11 47.18

Price Performance

Historical Comparison
REYN
TGTX

About REYN Reynolds Consumer Products Inc.

Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Share on Social Networks: